These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21519056)

  • 41. Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Moya Mur JL; Salido Tahoces L; Mestre Barcelo JL; Fernandez Golfín C; Zamorano Gómez JL
    Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):226. PubMed ID: 23988326
    [No Abstract]   [Full Text] [Related]  

  • 42. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Faber L
    Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
    Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
    Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertrophic obstructive cardiomyopathy and septal ablation.
    Steinbis S
    Crit Care Nurse; 2003 Jun; 23(3):47-50. PubMed ID: 12830780
    [No Abstract]   [Full Text] [Related]  

  • 45. Alcohol septal ablation after failed surgical myectomy.
    Joyal D; Arab D; Chen-Johnston C; Leya F
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):999-1002. PubMed ID: 17525959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alcohol Septal Ablation for Hypertrophic Cardiomyopathy Through an Anomalous Septal Perforator Off the Right Cusp.
    Mahowald MK; Corban MT; Eleid MF; Nishimura RA
    JACC Cardiovasc Interv; 2021 Jun; 14(12):e129-e130. PubMed ID: 34052152
    [No Abstract]   [Full Text] [Related]  

  • 47. In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size.
    Cheng TO
    Circulation; 2004 Jul; 110(3):e23; author reply e23. PubMed ID: 15262858
    [No Abstract]   [Full Text] [Related]  

  • 48. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
    Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
    Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Septal myectomy for hypertrophic cardiomyopathy: important surgical knowledge and technical tips in the era of increasing alcohol septal ablation.
    Chiang YP; Shimada YJ; Ginns J; Weiner SD; Takayama H
    Gen Thorac Cardiovasc Surg; 2018 Apr; 66(4):192-200. PubMed ID: 29450766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: The joys are brief: the results are lasting.
    Parakh N; Bhargava B
    JACC Cardiovasc Interv; 2009 Jan; 2(1):74; author reply 74-5. PubMed ID: 19463403
    [No Abstract]   [Full Text] [Related]  

  • 51. Percutaneous trans-apex intra-septal radiofrequency ablation of hypertrophic cardiomyopathy.
    Zuo L; Sun C; Yang J; Liu B; Zhou M; Guo R; Yu S; Ge J; Xiong L; Liu L
    Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):97-100. PubMed ID: 28949276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alcohol ablation of the interventricular septum in a patient with hypertrophic obstructive cardiomyopathy complicated by an increase in the pressure gradient in the left ventricular outflow tract. A case report].
    Płazak W; Podolec P; Krochin M; Gackowski A; Pieniazek P; Kapelak B; Sadowski J; Tracz W
    Kardiol Pol; 2006 Sep; 64(9):989-93. PubMed ID: 17054031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z; Wang F; Dou X; Zhang S; Pu J
    Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy.
    Jiang TY; Wu XS; Lu Q; Meng X; Jia CQ; Zhang Y
    Chin Med J (Engl); 2004 Feb; 117(2):296-8. PubMed ID: 14975219
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
    Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
    Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of echocardiography in hypertrophic cardiomyopathy.
    Williams LK; Gruner CH; Rakowski H
    Curr Cardiol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Kimmelstiel CD; Maron BJ
    Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
    [No Abstract]   [Full Text] [Related]  

  • 60. Layer-specific strain analysis of left ventricular myocardium after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Zhang J; Zhu L; Jiang X; Hu Z
    Medicine (Baltimore); 2018 Nov; 97(45):e13083. PubMed ID: 30407309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.